Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2025-12-26 @ 4:58 PM
Study NCT ID:
NCT01373151
Status:
COMPLETED
Last Update Posted:
2021-12-06
First Post:
2011-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate
Sponsor:
CSL Behring
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06
Start Date Type:
None
Primary Completion Date:
2012-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-06
Completion Date Type:
ACTUAL
First Submit Date:
2011-06-13
First Submit QC Date:
None
Study First Post Date:
2011-06-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-10-07
Results First Submit QC Date:
None
Results First Post Date:
2021-12-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-08-13
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-12-03
Last Update Post Date:
2021-12-06
Last Update Post Date Type:
ACTUAL